RxDoctor Payments Data

Rene Valles, MD

Child & Adolescent Psychiatry · Layton, UTNPI 1013015189

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (54.2%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. Corium, LLC accounts for 65.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $2,386 and has fallen 69.2% since, to $735 in 2025. Among child & adolescent psychiatry clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,534in general payments, 2019–2025

Across 50 payments — averaging $90.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corium, LLC$3K
  • Supernus Pharmaceuticals, Inc.$569
  • Tris Pharma Inc$545
  • Johnson & Johnson$143
  • Otsuka America Pharmaceutical, Inc.$125
  • Sunovion Pharmaceuticals Inc.$59
  • plus $108 from 3 others

What the payments were for

  • Consulting fees$3608%
  • Speaking & faculty fees$1,68037%
  • Travel & lodging$361%
  • Food & beverage$2,45954%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,534 in reported general payments places this provider in the 95th percentile of 29 child & adolescent psychiatry providers in Utah.

See all child & adolescent psychiatry providers in Utah

Medicare billing

Part B allowed, 2024
$1,412
Medicare patients
20
Services billed
89

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other child & adolescent psychiatry in Layton

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →